Chronic T-cell leukemias. II. Cytogenetic studies

Area of Science:

• Cytogenetics
• Hematology
• Oncology

Background:

• Chronic T-cell leukemias (T-PLL, T-CLL, T-LCL) are lymphoid malignancies with varying clinical outcomes.
• Understanding the underlying chromosomal abnormalities is crucial for diagnosis and prognosis.

Purpose of the Study:

• To investigate and compare chromosomal abnormalities in different types of chronic T-cell leukemias.
• To correlate specific karyotypic changes with clinical features and disease progression.

Main Methods:

• Analysis of PHA-stimulated lymphoid cells from 10 patients with chronic T-cell leukemias.
• Karyotyping to identify structural and numerical chromosome abnormalities.
• Comparison of chromosomal findings between T-cell prolymphocytic leukemia (T-PLL) and T-cell chronic lymphocytic leukemia (T-CLL).

Main Results:

• Consistent clonal marker chromosomes were found in all T-PLL cases, with unique abnormalities per patient.
• Structural abnormalities were less consistent in T-CLL and T-LCL.
• Chromosomes 2 and 8 were most frequently involved in numerical and structural abnormalities across T-cell leukemia subtypes.
• Abnormalities of chromosome 2, rare in other cancers, appeared common in these T-lymphoproliferative disorders.
• T-PLL exhibited clonal abnormalities and an aggressive clinical course, while T-CLL showed less consistent karyotypic changes and a benign evolution.

Conclusions:

• Distinct chromosomal abnormality patterns differentiate T-PLL from T-CLL.
• Karyotypic differences correlate with the clinical behavior of T-cell leukemias.
• Chromosome 2 abnormalities may be a specific feature of T-lymphoproliferative disorders.